The contents provided by this page is intended for members of the general public in the UK (including Northern Ireland). If you have been prescribed Remsima® (infliximab) or are a Healthcare Professional, please click here
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you consent to our use of cookies. For more information please see our Cookie Policy.
You are now leaving the site
You are now leaving the Celltrion Healthcare UK Ltd. website and entering an external site that is not under the review or control of Celltrion Healthcare UK Ltd. Celltrion Healthcare UK Ltd. does not take responsibility for its accuracy or content.